{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:10:08Z","timestamp":1792098608569,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.lpm.2018.03.005","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T19:23:38Z","timestamp":1528917818000},"page":"722-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Update on multiple endocrine neoplasia Type 1 and 2"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7951-9926","authenticated-orcid":false,"given":"Abdallah","family":"Al-Salameh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Baudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4140-586X","authenticated-orcid":false,"given":"R\u00e9gis","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2018.03.005_bib0160","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.03.005_bib0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2018.03.005_bib0170","first-page":"4776","article-title":"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.03.005_bib0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.lpm.2018.03.005_bib0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/89.9.653","article-title":"Clinical studies of multiple endocrine neoplasia type 1 (MEN1)","volume":"89","author":"Trump","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.lpm.2018.03.005_bib0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d\u2019etude des Tumeurs Endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2018.03.005_bib0190","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.lpm.2018.03.005_bib0195","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1074\/jbc.M114.629899","article-title":"Osteoblast menin regulates bone mass in vivo","volume":"290","author":"Kanazawa","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.lpm.2018.03.005_bib0200","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.soc.2015.06.008","article-title":"Multiple endocrine neoplasia: genetics and clinical management","volume":"24","author":"Norton","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.lpm.2018.03.005_bib0205","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/cen.13119","article-title":"Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients","volume":"85","author":"Qiu","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2018.03.005_bib0210","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lpm.2008.09.011","article-title":"Familial pituitary adenomas","volume":"38","author":"Burlacu","year":"2009","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2018.03.005_bib0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00268-017-4135-z","article-title":"Histologically proven bronchial neuroendocrine tumors in MEN1: a GTE 51-case cohort study","volume":"42","author":"Lecomte","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.lpm.2018.03.005_bib0220","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/cncr.28661","article-title":"RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma","volume":"120","author":"Krampitz","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2018.03.005_bib0225","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.03.005_bib0230","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/EJE-13-0050","article-title":"The clinical spectrum of RET proto-oncogene mutations in codon 790","volume":"169","author":"Bihan","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2018.03.005_bib0235","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.lpm.2018.03.005_bib0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.lpm.2018.03.005_bib0245","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ecl.2017.01.011","article-title":"Genetics of multiple endocrine neoplasia type 1\/multiple endocrine neoplasia type 2 syndromes","volume":"46","author":"Hyde","year":"2017","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.lpm.2018.03.005_bib0250","series-title":"GeneReviews(\u00ae) [Internet]","article-title":"Multiple Endocrine Neoplasia Type 2","author":"Marquard","year":"1993"},{"key":"10.1016\/j.lpm.2018.03.005_bib0255","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.lpm.2018.03.005_bib0260","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jc.2009-1728","article-title":"Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and Von Hippel-Lindau syndrome","volume":"95","author":"Erlic","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.03.005_bib0265","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/ERC-14-0491","article-title":"Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility","volume":"22","author":"Toledo","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.lpm.2018.03.005_bib0270","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","article-title":"Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d\u2019Etudes des Tumeurs a Calcitonine (GETC)","volume":"85","author":"Cohen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2018.03.005_bib0275","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.lpm.2018.03.005_bib0280","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.lpm.2016.04.012","article-title":"Management of gastrinoma","volume":"45","author":"Hain","year":"2016","journal-title":"Presse Med"},{"key":"10.1016\/j.lpm.2018.03.005_bib0285","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000002191","article-title":"Long-term follow-up of MEN1 patients who do not have initial surgery for small\u22642cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE study: Association francophone de chirurgie endocrinienne & groupe d\u2019\u00e9tude des tumeurs endocrines","author":"Triponez","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.lpm.2018.03.005_bib0290","article-title":"Management of MEN1 related nonfunctioning pancreatic NETs: a shifting paradigm: results From the DutchMEN1 Study Group","author":"Nell","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.lpm.2018.03.005_bib0295","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/thy.2008.0403","article-title":"Medullary thyroid cancer: management guidelines of the American Thyroid Association","volume":"19","author":"Kloos","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.lpm.2018.03.005_bib0300","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019\u00e9tude des tumeurs endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.lpm.2018.03.005_bib0305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","article-title":"Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d\u2019\u00e9tude des tumeurs \u00e0 calcitonine","volume":"48","author":"Modigliani","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.lpm.2018.03.005_bib0310","first-page":"1819","article-title":"Causes of death in patients with medullary cancer of the thyroid. GETC. Groupe d\u2019Etude des Tumeurs \u00e0 Calcitonine","volume":"25","author":"Cohen","year":"1996","journal-title":"Presse Med"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218301477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498218301477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T04:11:33Z","timestamp":1540527093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498218301477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0755498218301477"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2018.03.005","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on multiple endocrine neoplasia Type 1 and 2","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2018.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}